Sue Freeman, 78, checks her email at her home in Laguna Beach, Calif., on Saturday. She says her eyesight improved markedly since she received an experimental stem-cell procedure last July.
Melissa Forsyth for NPR
January 23, 2012 Sue Freeman, 78, is one of two women who appear to have unexpectedly regained some of their vision while taking part in a study testing the safety of an embryonic stem-cell therapy. The findings, if confirmed, could mark a landmark step in stem cell therapy, but everyone involved in the work is being very cautious about how they describe these results.
<iframe src="http://www.npr.org/player/embed/145636849/145656639" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
September 9, 2010 A U.S. appeals lifted temporarily a ban on federal funding of human embryonic stem cell funding.
September 7, 2010 A judge denied an Obama team request that he lift his ban on federal stem cell research funding. U.S. District Judge Royce Lamberth said the Obama Administration overstated the amount of harm that would arise from his ban.
August 31, 2010 The NIH warned of harm to research if a ban on federal funding of human embryo stell cell research. Francis Crick, the director of the federal institution, said discoveries could be lost and research deeply hurt.
NPR thanks our sponsors
Become an NPR sponsor